Randomized clinical trials of cardiovascular disease in obstructive sleep apnea: understanding and overcoming bias
Open accessThe DOI matches its Crossref record; 121 of the 122 references it cites were found in a registry or an index.
Abstract
Three recent randomized control trials (RCTs) found that treatment of obstructive sleep apnea (OSA) with continuous positive airway pressure (CPAP) did not reduce rates of future cardiovascular events. This article discusses the biases in these RCTs that may explain their negative results, and how to overcome these biases in future studies. First, sample selection bias affected each RCT. The subjects recruited were not patients typically presenting for treatment of OSA. In particular, subjects with excessive sleepiness were excluded due to ethical concerns. As recent data indicate that the excessively sleepy OSA subtype has increased cardiovascular risk, subjects most likely to benefit from treatment were excluded. Second, RCTs had low adherence to therapy. Reported adherence is lower than found clinically, suggesting it is in part related to selection bias. Each RCT showed a CPAP benefit consistent with epidemiological studies when restricting to adherent patients, but was underpowered. Future studies need to include sleepy individuals and maximize adherence. Since it is unethical and impractical to randomize very sleepy subjects to no therapy, alternative designs are required. Observational designs using propensity scores, which are accepted by FDA for studies of medical devices, provide an opportunity. The design needs to ensure covariate balance, including measures assessing healthy user and healthy adherer biases, between regular users of CPAP and non-users. Sensitivity analyses can evaluate the robustness of results to unmeasured confounding, thereby improving confidence in conclusions. Thus, these designs can robustly assess the cardiovascular benefit of CPAP in real-world patients, overcoming biases in RCTs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“RCTs also had inadequate adherence to PAP therapy and on secondary analysis of data in adherent patients, CPAP benefit was found to be consistent with prior epidemiological studies.1206”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [1206]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
The central role of the propensity score in observational studies for causal effects
ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241
Classification and Regression Trees.
Gordon, A. D., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984) · Biometrics · doi:10.2307/2530946 · Cited by 23,522
International physical activity questionnaire: 12-country reliability and validity
CRAIG, C. L., MARSHALL, A. L., SJ??STR??M, M., BAUMAN, A. E., BOOTH, M. L., AINSWORTH, B. E., PRATT, M., EKELUND, U., YNGVE, A., SALLIS, J. F., et al. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000078924.61453.fb · Cited by 21,619
The Occurrence of Sleep-Disordered Breathing among Middle-Aged Adults
Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S., & Badr, S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304293281704 · Cited by 10,183 · cited 2×
“While individuals with OSA from the general population can be a convenient source of recruitment, they tend to be relatively asymptomatic, raising questions as to the clinical significance of their disease [9, 58].”
BackgroundClassification and regression trees
Praagman, J. (1985) · European Journal of Operational Research · doi:10.1016/0377-2217(85)90321-2 · Cited by 10,053
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883
Austin, P. C. (2009) · Statistics in Medicine · doi:10.1002/sim.3697 · Cited by 6,758 · cited 1×
“This is most readily accomplished through comparisons of standardized mean differences between treatment groups (on both the original and absolute scales) before and after accounting for the PS design [101].”
MethodCholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
Research works printed but not linked: 3
- 17. follow-up from the Wisconsin sleep cohort. Arterioscler Thromb Vasc Biol. 2014; 34 (10):2338-2342.
- 84. FDA Center for Devices and Radiological Health. Design Considerations for Pivotal Clinical Investigations for Medical Devices: Guidance for Industry, Clinical Investigators, Institutional Review Boards and Food and Drug Administration Staff . Silver Spring, MD: Center for Devices and Radiological Health, FDA; 2013.
- 97. Maislin G, et al . Design of non-randomized medical device trials based on sub-classification using propensity score quintiles. Proc Joint Stat Meet, Biopharm Stat. 2010:2182-2196.
Cited by
International Consensus Statement on Obstructive Sleep Apnea
Chang, J. L., Goldberg, A. N., Alt, J. A., Mohammed, A., Ashbrook, L., Auckley, D., Ayappa, I., Bakhtiar, H., Barrera, J. E., Bartley, B. L., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23079 · Cited by 350
Self-citationRelationship Between CPAP Termination and All-Cause Mortality
Pépin, J., Bailly, S., Rinder, P., Adler, D., Benjafield, A., Lavergne, F., Josseran, A., Sinel-Boucher, P., Tamisier, R., Cistulli, P. A., et al. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.02.013 · Cited by 146
“Specifically, it recently was suggested that observational studies using propensity scores can overcome the ethical limitations around inclusion of patients with sleep apnea who experience excessive daytime sleepiness into randomized controlled trials.(22)”
BackgroundGervès‐Pinquié, C., Bailly, S., Goupil, F., Pigeanne, T., Launois, S. H., Leclair‐Visonneau, L., Masson, P., Bizieux‐Thaminy, A., Blanchard, M., Sabil, A., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202202-0366oc · Cited by 138
Lal, C., Ayappa, I. A., Ayas, N., Beaudin, A. E., Hoyos, C. M., Kushida, C. A., Kamińska, M., Mullins, A. E., Naismith, S. L., Osorio, R. S., et al. (2022) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202205-380st · Cited by 123
Obesity and Obstructive Sleep Apnea
Bonsignore, M. R. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_558 · Cited by 126
Reliability and Efficacy of the Epworth Sleepiness Scale: Is There Still a Place for It?
Scharf, M. T. (2022) · Nature and Science of Sleep · doi:10.2147/nss.s340950 · Cited by 124
“In fact, exclusion of patients with EDS in certain randomized controlled trials of OSA treatment has cast doubts on the generalizability of the findings.(7) However, despite the fact that EDS is clearly important, there is no consensus on the optimal way to assess EDS.”
BackgroundPinilla, L., Esmaeili, N., Gonzalo Labarca, T., Martínez‐García, M. Á., Torres, G., Gràcia‐Lavedan, E., Mínguez, O., Martínez, D., Abad, J., Masdeu, M. J., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00828-2023 · Cited by 100
“Several authors have discussed potential explanations that may shed light on these conflicting results [38, 39].”
Berry, R. B., Abreu, A. R., Krishnan, V., Quan, S. F., Strollo, P. J., & Malhotra, R. K. (2022) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.9952 · Cited by 84
“17 Thus, the RCTs to date targeting cardiometabolic outcomes have not been positive except for a study of the effect of CPAP on blood pressure in patients with a obstructive sleep apnea and resistant hypertension: (the HIPARCO randomized clinical trial).”
O’Donnell, C., Crilly, S., O'Mahony, A. M., O’Riordan, B., Traynor, M., Gitau, R., McDonald, K., Ledwidge, M. T., O'Shea, D. B., Murphy, D. J., et al. (2023) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202309-821oc · Cited by 77
Research routes on improved sleep bruxism metrics: Toward a standardised approach
Lavigne, G. J., Kato, T., Babiloni, A. H., Huynh, N. T., Fabbro, C. D., Svensson, P. J., Aarab, G., Ahlberg, J., Baba, K., Carra, M. C., et al. (2021) · Journal of Sleep Research · doi:10.1111/jsr.13320 · Cited by 70
Reynor, A., McArdle, N., Shenoy, B., Dhaliwal, S. S., Rea, S. C., Walsh, J. H., Eastwood, P. R., Maddison, K. J., Hillman, D. R., Ling, I., et al. (2021) · SLEEP · doi:10.1093/sleep/zsab264 · Cited by 67
Self-citationObstructive sleep apnea and stroke: The mechanisms, the randomized trials, and the road ahead
Javaheri, S., Peker, Y., Yaggi, H. K., & Bassetti, C. L. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2021.101568 · Cited by 67
Cavaillès, C., Berr, C., Helmer, C., Gabelle, A., Jaussent, I., & Dauvilliers, Y. A. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00952-y · Cited by 61
“Recent data suggested that excessively sleepy OSA subtype has the greatest increased cardiovascular risk compared to other types of OSA [30].”
BackgroundInfluentialAzarbarzin, A., Vena, D., Esmaeili, N., Wellman, A., Pinilla, L., Messineo, L., Zinchuk, A. V., Alex, R. M., Baumert, M., Loffler, K. A., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf447 · Cited by 67
Treatment of OSA and its Impact on Cardiovascular Disease, Part 2
Javaheri, S., Javaheri, S., Gozal, D., Campos‐Rodríguez, F., Martínez‐García, M. Á., Mokhlesi, B., Mehra, R., McNicholas, W. T., Somers, V. K., Zee, P. C., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.07.024 · Cited by 54
Obstructive Sleep Apnea and Cardiovascular Disease: Where Do We Stand?
Peker, Y., Akdeniz, B., Altay, S., Balcan, B., Başaran, Ö., Baysal, E., Çelik, A., Dursunoğlu, D., Dursunoğlu, N., Fırat, S., et al. (2023) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2023.3307 · Cited by 64
Obstructive sleep apnea therapy for cardiovascular risk reduction—Time for a rethink?
Dissanayake, H. U., Colpani, J. T., Sutherland, K., Loke, W., Mohammadieh, A. M., Ou, Y.-H., de Chazal, P., Cistulli, P. A., & Lee, C. (2021) · Clinical Cardiology · doi:10.1002/clc.23747 · Cited by 42
“Various explanations for these conflicting findings have been proposed.(10) These include poor CPAP adherence among trial participants who did not experience excessive daytime sleepiness, limited ability of the apnea–hypopnea index (the conventional measure of OSA severity) to risk-stratify patients with OSA, and the…”
BackgroundPositive Airway Pressure, Mortality, and Cardiovascular Risk in Older Adults With Sleep Apnea
Mazzotti, D. R., Waitman, L. R., Miller, J. N., Sundar, K. M., Stewart, N. H., Gozal, D., Song, X., Collaborative, G. P., Chandaka, S., Anuforo, K., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.32468 · Cited by 47
Patil, S. P., Billings, M. E., Bourjeily, G. R., Collop, N. A., Gottlieb, D. J., Johnson, K. G., Kimoff, R. J., & Pack, A. I. (2023) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.10832 · Cited by 46
“111,112 Adaptive trials: Adaptive trial designs 100,112,115 are trials that offer “ pre-planned opportunities to use accumulating trial data to modify aspects of an ongoing trial while preserving the validity and integrity of that trial.”
Self-citationCancer risk in patients with sleep apnoea following adherent 5-year CPAP therapy
Justeau, G., Bailly, S., Gervès‐Pinquié, C., Trzépizur, W., Meslier, N., Goupil, F., Pigeanne, T., Launois, S. H., Leclair‐Visonneau, L., Masson, P., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.01935-2021 · Cited by 40
zu Eulenburg, C., Çelik, Y., Redline, S. S., Thunström, E. Ö., Glantz, H., Strollo, P. J., & Peker, Y. (2023) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202208-676oc · Cited by 36
Eshera, Y. M., Gavrilova, L., & Hughes, J. W. (2023) · American Journal of Lifestyle Medicine · doi:10.1177/15598276231211846 · Cited by 35
“79 Speci fi cally, the international Sleep Apnea and Cardiovascular Endpoints (SAVE) study examined mostly male patients with moderate-to-severe OSA split between a CPAP group and a usual-care group.”
BackgroundDedhia, R. C., Bliwise, D. L., Quyyumi, A. A., Thaler, E. R., Boon, M. S., Huntley, C. T., Seay, E. G., Tangutur, A., Strollo, P. J., Gurel, N. Z., et al. (2023) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2023.3756 · Cited by 33
Self-citationRole of precision medicine in obstructive sleep apnoea
Liu, Y., Ghafoor, A. A., Hajipour, M., & Ayas, N. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2022-000218 · Cited by 33
Donovan, L. M., Hoyos, C. M., Kimoff, R. J., Morrell, M. J., Bosch, N. A., Chooljian, D. M., McEvoy, R. D., Sawyer, A. M., Wagner, T. H., Al-Lamee, R. K., et al. (2023) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202303-258st · Cited by 30
“Propensity score – based methods are often used to compare individuals who are adherent to CPAP relative to those with similar observed characteristics who are nonadherent (7, 22, 23, 37).”
Cluster-derived obstructive sleep apnea phenotypes and outcomes at 5-year follow-up
Silveira, M. G., Sampol, G., Mota-Foix, M., Ferrer, J., & Lloberes, P. (2021) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.9674 · Cited by 31
“26 Clusters 1 and 3 had moderate OSA.”
Bradicich, M., Pengo, M. F., Steier, J. S., & Schwarz, E. I. (2024) · ERJ Open Research · doi:10.1183/23120541.00718-2024 · Cited by 24
“Intention-to-treat analyses have shown no statistically significant effect of CPAP on the combined end-point of MACE, but treatment adherence to CPAP was modest or low [40].”
McEvoy, R. D., Sánchez‐de‐la‐Torre, M., Peker, Y., Anderson, C. S., Redline, S. S., & Barbé, F. (2021) · SLEEP · doi:10.1093/sleep/zsab019 · Cited by 23
“[1] have been too hasty in dismissing their value in advancing knowledge and clinical decision-making and appear misinformed in their belief that only sleepy patients are at increased CV risk.”
BackgroundInfluentialEffect of CPAP Treatment on Cardiovascular Outcomes
de Batlle, J., Gràcia‐Lavedan, E., Escarrabill, J., García‐Altés, A., Martínez-Carbonell, E., Henríquez‐Beltrán, M., Sánchez‐de‐la‐Torre, M., & Barbé, F. (2024) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2024.05.029 · Cited by 26
OSA symptom subtypes and hypoxic burden independently predict distinct cardiovascular outcomes
Mazzotti, D. R., Magalang, U. J., Keenan, B. T., Mindel, J. W., Younes, M. K., Penzel, T., Pack, A. I., & de Chazal, P. (2024) · ERJ Open Research · doi:10.1183/23120541.00511-2024 · Cited by 24
“…to claims as to the “ value of HB – and not symptom subtypes – in the prediction of cardiovascular events and mortality ” [19], others have raised alternative explanations for the inconsistent findings [31, 32], such as the higher prevalence of CPAP treatment among excessively sleepy patients [10].”
Self-citationWhy could sleep medicine never do without polysomnography?
Gauld, C., & Micoulaud‐Franchi, J. (2021) · Journal of Sleep Research · doi:10.1111/jsr.13541 · Cited by 21
Tan, J. W. C., Leow, L. C., Wong, S., Khoo, S. M., Kasai, T., Kojodjojo, P., Duong‐Quy, S., Lee, C. P., Chirakalwasan, N., Li, H., et al. (2022) · European Cardiology Review · doi:10.15420/ecr.2021.59 · Cited by 17
Obstructive sleep apnoea–hypopnoea syndrome
Read, N., Jennings, C., & Hare, A. (2023) · Emerging Topics in Life Sciences · doi:10.1042/etls20180939 · Cited by 16
The Global Socioeconomic Burden of Obstructive Sleep Apnea: A Comprehensive Review
Zappalà, P., Lentini, M., Ronsivalle, S., Lavalle, S., Via, L. L., & Maniaci, A. (2025) · Healthcare · doi:10.3390/healthcare13172115 · Cited by 22
“The consult and treatment lag times are also, in general, longer in the public healthcare system, with a mean delay of at least 8 months to 1 year at some sites [39].”
Symptom subtypes of obstructive sleep apnea 10 years later: past, present, and future
Keenan, B. T., Ye, L., Pien, G. W., Magalang, U. J., Benediktsdóttir, B., Gíslason, Þ., & Pack, A. I. (2025) · SLEEP · doi:10.1093/sleep/zsaf082 · Cited by 16
Self-citationBettega, F., Leyrat, C., Tamisier, R., Mendelson, M., Grillet, Y., Sapène, M., Bonsignore, M. R., Pépin, J., Kattan, M. W., & Bailly, S. (2022) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202109-1036oc · Cited by 17
Unmasking Heterogeneity of Sleep Apnea
Pack, A. I. (2023) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2023.05.003 · Cited by 15
Self-citationJacobowitz, O., Schwartz, A. R., Lovett, E. G., Ranuzzi, G., & Malhotra, A. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.106804 · Cited by 19
Patel, S. R., Bakker, J. P., Stitt, C. J., Hardy, W., Aloia, M. S., & Nouraie, M. S. (2022) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202204-310oc · Cited by 15
Mills, E. W., Antman, E. M., & Javaheri, S. (2023) · Heart Rhythm · doi:10.1016/j.hrthm.2023.04.022 · Cited by 17
Impact of sleep apnea and treatments on cardiovascular disease
de Faria, A. O. V., Macedo, A. C., de Castro, C. C. C., Valle, E., Lacerda, R., Ayas, N., & Laher, I. (2022) · Sleep Science · doi:10.5935/1984-0063.20220047 · Cited by 22
“In addition, it must be recognized that the patients in the SAVE study were in general not sleepy and CPAP adherence was low; these may have also contributed to the null results 94,95 .”
BackgroundDevinney, M. J., VanDusen, K. W., Kfouri, J. M., Avasarala, P., Spector, A. R., Mathew, J. P., & Berger, M. (2022) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-022-02302-4 · Cited by 18
“This is because it is challenging to adhere to CPAP because of patient discomfort and cultural and socioeconomic barriers.(8)”
BackgroundBreaking Ground: From CPAP Treatment to the First Medicine for OSA Patients with Obesity
Lisik, D., & Zou, D. (2025) · Current Pulmonology Reports · doi:10.1007/s13665-024-00365-w · Cited by 12
“…limited long-term protective effect against cardiovascular [10] and neurocognitive [11] outcomes which is partly explained by suboptimal adherence [12], but also by different endotypic/phenotypic patterns inadequately targeted by PAP [13] as well as comorbidities influencing OSA pathogenesis and…”
Obtaining Valid Estimates of the Effect of CPAP Therapy
Kapur, V. K., & Psaty, B. M. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.03.027 · Cited by 11
Elbadawi, A., Elgendy, I. Y., Shnoda, M., Abuzaid, A., Barssoum, K. N., Gouda, M., Megaly, M. S., Bansal, A., Gulati, M., & Jneid, H. M. (2021) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2021.100056 · Cited by 14
“Proposedly future trials should pursue alternate designs in order to maximize CPAP adherence rates among participants, and importantly enroll sleepy patients with OSA who would hypothetically have more benefit from CPAP therapy [26].”
BackgroundObstructive sleep apnea during REM sleep and hypertension: new findings from a clinical cohort
McCullough, L. M., & Mokhlesi, B. (2023) · SLEEP · doi:10.1093/sleep/zsad003 · Cited by 10
Евгеньевна, Р. А., Zhuravlev, M. О., Orlova, A. A., Викторович, А. М., Drapkina, O. M., & Kiselev, A. R. (2023) · The European Physical Journal Special Topics · doi:10.1140/epjs/s11734-023-01056-4 · Cited by 9
“The study of nocturnal sleep is currently a highly relevant task that is being addressed by a significant number of researchers around the world, both as part of the development of interdisciplinary approaches [1–3] and clinical research [4].”
Huang, Z., Zhao, Q., Zhao, Z., THOMAS, R. J., Duan, A., Li, X., Zhang, S., Gao, L., An, C., Wang, Y., et al. (2024) · Sleep Medicine · doi:10.1016/j.sleep.2024.12.019 · Cited by 12
Pengo, M. F., Gozal, D., & Martínez‐García, M. Á. (2022) · SLEEP · doi:10.1093/sleep/zsac208 · Cited by 9
Risk of Severe COVID-19 in Non-Adherent OSA Patients
Genzor, S., Praško, J. P., Mizera, J., Jakubec, P., Sova, M., Vaněk, J., Šurinová, N., & Langová, K. (2022) · Patient Preference and Adherence · doi:10.2147/ppa.s387657 · Cited by 11
“This may be explained by the lack of matched controls in the clinical studies, as it is unethical not to treat symptomatic OSA patients.(34)”
BackgroundBraun, M., Wollny, M., Schoebel, C., Sommer, J. U., & Heiser, C. (2023) · Sleep And Breathing · doi:10.1007/s11325-023-02887-0 · Cited by 10
“In addition to its use in diagnostic assessment, the ESS is also widely used to evaluate the efficacy of interventions to treat OSA and is a common subjective endpoint in clinical trials [11].”
MethodPatel, S. R., Sawyer, A. M., & Gottlieb, D. J. (2024) · SLEEP · doi:10.1093/sleep/zsae063 · Cited by 8
Keenan, B. T., Magalang, U. J., Mazzotti, D. R., McArdle, N., Gíslason, Þ., Singh, B., Maislin, G., & Pack, A. I. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202111-2467le · Cited by 9
Self-citationMagalang, U. J., & Keenan, B. T. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.09.022 · Cited by 11
Self-citationTo RCT or not to RCT? Depends on the question. A response to McEvoy et al.
Pack, A. I., Magalang, U. J., Singh, B., Kuna, S. T., Keenan, B. T., & Maislin, G. (2021) · SLEEP · doi:10.1093/sleep/zsab042 · Cited by 8
“As evidenced by the APPLES study [22] and noted in our commentary [2], more symptomatic patients remain less willing to participate in trials when they may be randomized to no therapy for long periods of time, regardless of whether or not they are explicitly excluded.”
BackgroundInfluentialSelf-citationEffect of obstructive sleep apnoea on retinal microvascular function: a randomised controlled trial
Turnbull, C. D., Stockley, J. A., Madathil, S. C., Huq, S., Cooper, B. G., Ali, A., Wharton, S., Stradling, J. R., & Heitmar, R. (2022) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-022-05596-8 · Cited by 8
Hamada, S., Togawa, J., Sunadome, H., Nagasaki, T., Takahashi, N., Hirai, T., & Satô, S. (2024) · Sleep Science · doi:10.1055/s-0043-1776741 · Cited by 7
The search for realistic evidence on the outcomes of obstructive sleep apnoea
Schiza, S. E., Levy, P. A., Martínez‐García, M. Á., Pépin, J., Simonds, A. K., & Randerath, W. J. (2021) · European Respiratory Journal · doi:10.1183/13993003.01963-2021 · Cited by 9
Fabbro, C. D., Harris, P., Dufresne, E., Babiloni, A. H., Mayer, P., Bahig, H., Filion, É., Nguyen, F., Ghannoum, J., Schmittbuhl, M., et al. (2022) · Journal of Oral & Facial Pain and Headache · doi:10.11607/ofph.3176 · Cited by 8
Olszowka, M., Hagström, E., Hadziosmanovic, N., Ljunggren, M. E., Denchev, S. V., Manolis, A. J., Wallentin, L. C., White, H. D., Stewart, R., & Held, C. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131395 · Cited by 6
Keenan, B. T., Magalang, U. J., & Maislin, G. (2024) · SLEEP · doi:10.1093/sleep/zsae064 · Cited by 6
Self-citationNatale, A., & Mohanty, S. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf460 · Cited by 5
Management of Adult Obstructive Sleep Apnoea: Many Questions, Not Enough Answers!
Stanczyk, M., McNicholas, W. T., Pevernagie, D., Riha, R. L., & Ryan, S. (2025) · Journal of Sleep Research · doi:10.1111/jsr.70047 · Cited by 7
Obstructive sleep apnea and atrial fibrillation: we need to go step by step
Sánchez‐de‐la‐Torre, M., Lee, C., & Barbé, F. (2021) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.9242 · Cited by 5
Atrial Fibrillation, Obstructive Sleep Apnea, and Continuous Positive Airway Pressure: No Easy Fix
Hind, M. D., & Wong, T. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202105-1208ed · Cited by 5
Keenan, B. T., & Heinzer, R. C. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202207-1359ed · Cited by 5
Self-citationGonzalo Labarca, T., & Singh, B. (2024) · CHEST Journal · doi:10.1016/j.chest.2023.12.021 · Cited by 6
Self-citationGuo, R., Guo, Q., Hao, W., Fan, J., Nie, S., & Wang, X. (2024) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2023.0086 · Cited by 4
Obstruktive Schlafapnoe – Einfluss auf kardiovaskuläres System und Kognition
Schneider, G. (2023) · Laryngo-Rhino-Otologie · doi:10.1055/a-1963-9957 · Cited by 12
Linh, T. T. D., Trang, N. T. H., Lin, S., Wu, D., Liu, W., & Hu, C. (2023) · Journal of Sleep Research · doi:10.1111/jsr.13991 · Cited by 5
“However, adherence to CPAP is low (Contal et al., 2021; Pack et al., 2021), partly due to suboptimal pressure management, which can result in patients experiencing residual apneic or hypopneic episodes.”
BackgroundCardiovascular Complications of Obstructive Sleep Apnea in the Intensive Care Unit and Beyond
Wahab, A., Chowdhury, A. R., Jain, N. K., Surani, S., Mushtaq, H. A., Khedr, A., Mir, M., Jama, A. B., Rauf, I., Jain, S., et al. (2022) · Medicina · doi:10.3390/medicina58101390 · Cited by 8
“impact of PAP therapy on cardiovascular diseases in OSA [67].”
BackgroundMazzotti, D. R., Waitman, L. R., Miller, J. J., Sundar, K. M., Stewart, N. H., Gozal, D., Song, X., & Collaborative, G. P. (2024) · Sleep Medicine · doi:10.1016/j.sleep.2023.11.1013 · Cited by 4
Kalaydzhiev, P., Borizanova, A., Georgieva, N., Voynova, G., Yakov, S., Kocev, T., Tomova-Lyutakova, G., Krastev, B., Spasova, N., Ilieva, R., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195676 · Cited by 4
“…with chronic heart failure (CHF) and OSA by reducing sympathetic activity, lowering blood pressure, and improving left ventricular function [10–13]; however, the efficacy of CPAP in patients with CSA remains controversial as it may not address the underlying central respiratory instability [14].”
BackgroundHsu, Y., Wang, J., Chang, S., Chiu, C., Chien, Y., & Lin, C.-Y. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195748 · Cited by 6
“These restrictions may not adequately capture the diversity among individuals with OSA [3,16–18], thereby potentially limiting the generalizability of their findings.”
BackgroundPhenotypic Characterisation of Obstructive Sleep Apnoea in Acute Coronary Syndrome
Tong, B., Ucak, S., Dissanayake, H. U., Patel, S. A., Stewart, G. M., Sutherland, K., Yee, B. J., Allahwala, U. K., Bhindi, R., de Chazal, P., et al. (2024) · Heart Lung and Circulation · doi:10.1016/j.hlc.2024.07.014 · Cited by 4
Park, Y., & Yun, H. J. (2022) · Journal of Korean Academy of Fundamentals of Nursing · doi:10.7739/jkafn.2022.29.1.67 · Cited by 3
“수면의 질이 낮을 경우 염증성 지표가 증가 하면서 면역계 기능이 저하되어 만성질환의 증가와 사망률을 증가시키며[1], 심혈관 질환 이환율 증가와 사망률을 증가시킨 다[2].”
O’Donnell, C., Crilly, S., O'Mahony, A. M., O'Riordan, B. C., Traynor, M., Gitau, R., McDonald, K., Ledwidge, M. T., O'Shea, D. B., Murphy, D. J., et al. (2023) · medRxiv · doi:10.1101/2023.05.23.23290424 · Cited by 3
Shahu, A., Chung, J., Tarraf, W., Ramos, A. R., González, H. M., Redline, S. S., Cai, J., & Sofer, T. (2023) · Scientific Reports · doi:10.1038/s41598-023-36927-2 · Cited by 4
“Thus, researchers have called for greater use of causal inference methods in observational sleep studies to assess the potential impact of treatment effects 4 .”
Glucagon‐Like Peptide‐1 Receptor Agonist Utilization Among Sleep Surgery Clinic Patients
Kutler, R. B., Lin, A., Zhang, L., Trackey, P., Rivera‐Diaz, A., Jelić, S., St‐Onge, M., & Cai, Y. (2026) · Otolaryngology · doi:10.1002/ohn.70231 · Cited by 2
Donovan, L. M., Wai, T. Y. H., Spece, L. J., Duan, K. I., Griffith, M. F., Leonhard, A., Plumley, R., Hayes, S. A., Picazo, F., Crothers, K. A., et al. (2023) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202303-275oc · Cited by 2
Uncovering the effect of CPAP on cardiovascular outcomes in obstructive sleep apnea
Singh, B., & Mazzotti, D. R. (2024) · SLEEP · doi:10.1093/sleep/zsae153 · Cited by 3
Self-citationDeveloping a Personalized Approach to Obstructive Sleep Apnea
Pack, A. I. (2024) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2024.10.008 · Cited by 2
Self-citationSyndrome d’apnées du sommeil 1999–2022 : des essais randomisés aux études de cohorte
Levy, P. A., Tamisier, R., & Pépin, J. (2023) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2022.10.022 · Cited by 3
CPAP therapy for obstructive sleep apnoea: are the right questions being asked?
Gottlieb, D. J. (2023) · European Respiratory Journal · doi:10.1183/13993003.00575-2023 · Cited by 2
Locke, B. W., Neill, S. E., Howe, H. E., Crotty, M. C., Kim, J., & Sundar, K. M. (2021) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.9750 · Cited by 3
Ou, Y.-H., Thant, A. T., & Lee, C. (2022) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.9880 · Cited by 2
“9 However, the cause of this poor adherence remains unclear.”
Unraveling the Healthy Adherer Effect in the Clinical Management of Sleep Apnea With CPAP
Patel, S. R. (2024) · CHEST Journal · doi:10.1016/j.chest.2024.06.3795 · Cited by 2
Aneni, E. C., Sinusas, A. J., Emokpae, M. C., Thorn, S., Yaggi, H. K., & Miller, E. J. (2024) · Current Cardiology Reports · doi:10.1007/s11886-024-02072-z · Cited by 2
“Two major limitations of these RCTs were the inability to recruit symptomatic (i.e., sleepy) patients due to ethical concerns with randomization of these patients and the low adherence to CPAP therapy [34].”
Zhang, Y., Somers, V. K., & Tang, X. (2025) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(25)00015-3 · Cited by 1
Jaffuel, D., Nogué, E., Roubille, F., Mallet, J., Bailly, S., Goupil, F., Thomas, A., Hervé, C., Masson, P., Bizieux‐Thaminy, A., et al. (2025) · ERJ Open Research · doi:10.1183/23120541.00081-2025 · Cited by 2
“Using real-world observational data provides an alternative approach [14 – 16] that overcomes problems associated with the RCTs, such as the study duration and the randomisation of PAP therapy [17] for symptomatic patients for whom the benefit of PAP has been demonstrated.”
Mazzotti, D. R., Chen, A., An, J., Chung, J., Arguelles, J., Keenan, B. T., Maislin, G., Saconi, B., Watach, A. J., Glick, H. A., et al. (2025) · Sleep Medicine · doi:10.1016/j.sleep.2025.108732 · Cited by 2
“High-lighting the impact of low adherence on study conclusions, secondary analysis restricted to patients with increased adherence showed CPAP benefits that are consistent with what was observed by cohort studies [21,22], yet were underpowered to detect effects as significant [25].”
InfluentialSelf-citationMartínez‐García, M. Á., Oscullo, G., & Gómez-Olivas, J. D. (2022) · SLEEP · doi:10.1093/sleep/zsac021 · Cited by 1
A Narrative Review of the Clinical Trials in Sleep-Related Breathing Disorders from 2022 to Present
Pıhtılı, A., Gürkan, C. G., Habeşoğlu, M. A., Öztürk, Ö., Uğurlu, A. Ö., Taşbakan, M. S., Peker, Y., & On behalf of the Turkish Thoracic Society Sleep Related Breathing Disorders Working Group (2023) · Thoracic research and practice · doi:10.5152/thoracrespract.2023.23104 · Cited by 1
Sleep surgery improves blood pressure: How can it be?
Weaver, E. M. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2022.101619 · Cited by 2
Approaching sleep apnea management in the setting of uncertainty
Donovan, L. M., & Patel, S. R. (2022) · SLEEP · doi:10.1093/sleep/zsac234 · Cited by 1
“Many attribute the negative results for CPAP in secondary prevention trials to low adherence [15, 16].”
BackgroundBailly, S., Gervès‐Pinquié, C., & Gagnadoux, F. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202208-1534le · Cited by 1
Untangling Treatment Effect From Patient Factors
Albrecht, J. S., & Kapur, V. K. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.03.018 · Cited by 1
Can’t touch this: the emergence of contactless sleep technology
Yoo, A., & Anafi, R. C. (2024) · SLEEP · doi:10.1093/sleep/zsae207 · Cited by 1
“Furthermore, several randomized CPAP trials have not shown a survival benefit when patients are selected using standard AHI criteria [12].”
Tirzepatide, Mortality, Cardiovascular, and Renal Outcomes in Sleep Apnea
Mazzotti, D. R., & Stevens, D. R. (2025) · CHEST Journal · doi:10.1016/j.chest.2025.05.019 · Cited by 1
Metadata
- Authors
- Pack, A. I., Magalang, U. J., Singh, B., Kuna, S. T., Keenan, B. T., & Maislin, G.
- Affiliations
- University of Pennsylvania (US)
- The Ohio State University Wexner Medical Center (US)
- Sir Charles Gairdner Hospital (AU)
- Philadelphia VA Medical Center (US)
- Corresponding author
- Pack, Allan I
- Venue
- Sleep
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-11-09
- Volume
- 44
- Issue
- 2
- ISSN
- 0161-8105 (ISSN-L)
- 1550-9109
- PMC
- PMC7879410
- OpenAlex
- W3103233613
- Cited by
- 114
- References
- 122
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 23 · 2023: 26 · 2022: 27 · 2021: 21
- FWCI
- 11.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- SLEEP (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (P01 HL094307)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
- Keywords
- obstructive sleep apnea, continuous positive airway pressure, cardiovascular events, sample selection bias, excessive daytime sleepiness, CPAP adherence, healthy user bias, propensity score, observational study design, sensitivity analysis, unmeasured confounding, cardiovascular risk
- MeSH terms
- Cardiovascular Diseases, Humans, Patient Compliance, Bias, Randomized Controlled Trials as Topic, Sleep Apnea, Obstructive, Continuous Positive Airway Pressure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.